Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IMX-110 |
Trade Name | |
Synonyms | IMX110|IMX 110 |
Drug Descriptions |
IMX-110 is a nanoparticle formulation of curcumin and doxorubicin, which may decrease tumor cell growth and induce tumor cell apoptosis (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C154569 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IMX-110 | IMX-110 | 0 | 1 |
IMX-110 + Tislelizumab | IMX-110 Tislelizumab | 0 | 1 |